(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
0.17% $ 6.02
@ $8.60
Wydano: 14 vas. 2024 @ 22:09
Zwrot: -30.00%
Poprzedni sygnał: vas. 14 - 19:47
Poprzedni sygnał:
Zwrot: -2.05 %
Live Chart Being Loaded With Signals
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors...
Stats | |
---|---|
Dzisiejszy wolumen | 912 095 |
Średni wolumen | 2.15M |
Kapitalizacja rynkowa | 575.59M |
EPS | $0 ( 2024-03-12 ) |
Następna data zysków | ( $-0.500 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.49 |
ATR14 | $0.00500 (0.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Ferrante Karen Jean | Buy | 3 213 | Stock Option (Right to Buy) |
2024-03-28 | Fairmount Funds Management Llc | Buy | 286 851 | Common Stock |
2024-03-28 | Fairmount Funds Management Llc | Buy | 11 914 | Series A Convertible Preferred Stock |
2024-03-28 | Fairmount Funds Management Llc | Sell | 11 914 | Series A Convertible Preferred Stock |
2024-03-28 | Fairmount Funds Management Llc | Sell | 286 851 | Common Stock |
INSIDER POWER |
---|
88.06 |
Last 97 transactions |
Buy: 19 542 341 | Sell: 1 316 263 |
Wolumen Korelacja
Cogint Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
NWL | 0.911 |
CPIX | 0.903 |
PRAX | 0.9 |
CNDT | 0.891 |
EWTX | 0.89 |
QMCO | 0.887 |
AQB | 0.886 |
AVDX | 0.886 |
SRTS | 0.885 |
CHB | 0.885 |
10 Najbardziej negatywne korelacje | |
---|---|
PPBT | -0.881 |
FIZZ | -0.864 |
EPZM | -0.833 |
SNCR | -0.822 |
XOG | -0.821 |
TYHT | -0.816 |
LEDS | -0.805 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cogint Inc. Korelacja - Waluta/Towar
Cogint Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-3.59M (0.00 %) |
EPS: | $-2.42 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-3.59M (0.00 %) |
EPS: | $-2.42 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-5.88M (0.00 %) |
EPS: | $-2.26 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.814 |
Financial Reports:
No articles found.
Cogint Inc.
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej